LIF significantly upregulates the phosphorylation of JAK1 and sustains JAK1/STAT3 signalling by binding to the receptor LIFR, strongly preventing the differentiation of HCC cells and promoting the metastasis and an immunosuppressive phenotype of prostate cancer [124–126]. This evidence concerns the gene JAK1 and prostate carcinoma.